Nadège Pelletier

1.2k total citations
17 papers, 891 citations indexed

About

Nadège Pelletier is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Nadège Pelletier has authored 17 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Nadège Pelletier's work include Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (5 papers). Nadège Pelletier is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (5 papers). Nadège Pelletier collaborates with scholars based in France, Switzerland and United States. Nadège Pelletier's co-authors include Michael G. McHeyzer‐Williams, Nicolas Fazilleau, Louise J. McHeyzer‐Williams, Linda Mark, Kai‐Michael Toellner, Michael Meyer‐Hermann, Yang Zhang, Elodie Mohr, Gabriel D. Victora and Eduard Urich and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Nature Immunology.

In The Last Decade

Nadège Pelletier

17 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadège Pelletier France 11 524 285 181 128 116 17 891
Peter von Wussow Germany 22 647 1.2× 232 0.8× 146 0.8× 317 2.5× 158 1.4× 44 1.3k
Alessandra Bettinardi Italy 11 601 1.1× 153 0.5× 99 0.5× 157 1.2× 193 1.7× 14 998
Vittorio Francavilla Italy 16 878 1.7× 316 1.1× 344 1.9× 148 1.2× 157 1.4× 31 1.3k
Hyun‐Tak Jin South Korea 10 592 1.1× 235 0.8× 74 0.4× 371 2.9× 149 1.3× 12 908
Isabelle Moreau France 15 286 0.5× 135 0.5× 145 0.8× 89 0.7× 119 1.0× 25 618
Noriyoshi Kuzushita Japan 21 521 1.0× 563 2.0× 697 3.9× 139 1.1× 200 1.7× 36 1.3k
Ann‐Margaret Little United Kingdom 24 1.2k 2.4× 259 0.9× 143 0.8× 234 1.8× 232 2.0× 55 1.8k
Paul L. Klarenbeek Netherlands 19 561 1.1× 246 0.9× 44 0.2× 185 1.4× 152 1.3× 35 1.0k
Xiao-Song He United States 10 629 1.2× 540 1.9× 626 3.5× 82 0.6× 167 1.4× 10 1.3k
D Jakschies Germany 14 396 0.8× 128 0.4× 87 0.5× 167 1.3× 83 0.7× 16 639

Countries citing papers authored by Nadège Pelletier

Since Specialization
Citations

This map shows the geographic impact of Nadège Pelletier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Pelletier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Pelletier more than expected).

Fields of papers citing papers by Nadège Pelletier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadège Pelletier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Pelletier. The network helps show where Nadège Pelletier may publish in the future.

Co-authorship network of co-authors of Nadège Pelletier

This figure shows the co-authorship network connecting the top 25 collaborators of Nadège Pelletier. A scholar is included among the top collaborators of Nadège Pelletier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadège Pelletier. Nadège Pelletier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Beretta, Maxime, Cyril Planchais, Pierre Rosenbaum, et al.. (2024). Enhanced hepatitis B virus–specific immunity by combining neutralizing antibody therapy and DNA vaccination in a murine model of chronic hepatitis B virus infection. Hepatology. 82(2). 470–486. 1 indexed citations
2.
Hatje, Klas, Tony Kam‐Thong, Nicolas Giroud, et al.. (2024). Single-cell RNA-sequencing of virus-specific cellular immune responses in chronic hepatitis B patients. Scientific Data. 11(1). 355–355. 1 indexed citations
3.
Beretta, Maxime, Maryline Bourgine, Malika Ait‐Goughoulte, et al.. (2020). Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers. The Journal of Experimental Medicine. 217(10). 44 indexed citations
4.
Burton, Alice R., Laura J. Pallett, Laura E. McCoy, et al.. (2018). Circulating and intrahepatic antiviral B cells are defective in hepatitis B. Journal of Clinical Investigation. 128(10). 4588–4603. 222 indexed citations
5.
Pao, William, Chia-Huey Ooi, Fabian Birzele, et al.. (2018). Tissue-Specific Immunoregulation: A Call for Better Understanding of the “Immunostat” in the Context of Cancer. Cancer Discovery. 8(4). 395–402. 63 indexed citations
6.
Meyer‐Hermann, Michael, Elodie Mohr, Nadège Pelletier, et al.. (2012). A Theory of Germinal Center B Cell Selection, Division, and Exit. Cell Reports. 2(1). 162–174. 127 indexed citations
7.
Dosenovic, Pia, Jean L. Scholz, Sijy O’Dell, et al.. (2012). BLyS-Mediated Modulation of Naive B Cell Subsets Impacts HIV Env-Induced Antibody Responses. The Journal of Immunology. 188(12). 6018–6026. 27 indexed citations
8.
Pelletier, Nadège, Louise J. McHeyzer‐Williams, K. Wong, et al.. (2010). Plasma cells negatively regulate the follicular helper T cell program. Nature Immunology. 11(12). 1110–1118. 113 indexed citations
9.
McHeyzer‐Williams, Louise J., Nadège Pelletier, Linda Mark, Nicolas Fazilleau, & Michael G. McHeyzer‐Williams. (2009). Follicular helper T cells as cognate regulators of B cell immunity. Current Opinion in Immunology. 21(3). 266–273. 147 indexed citations
10.
Pelletier, Nadège, Montserrat Casamayor‐Palleja, Karelle De Luca, et al.. (2006). The Endoplasmic Reticulum Is a Key Component of the Plasma Cell Death Pathway. The Journal of Immunology. 176(3). 1340–1347. 51 indexed citations
11.
Contin, Cécile, Vincent Pitard, Yahsou Delmas, et al.. (2003). Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients. Immunology. 110(1). 131–140. 57 indexed citations
12.
Michel, Marc, Jean‐Charles Piette, E Roullet, et al.. (2000). The R131 low-affinity allele of the Fc gamma RIIA receptor is associated with systemic lupus erythematosus but not with other autoimmune diseases in French Caucasians. The American Journal of Medicine. 108(7). 580–583. 11 indexed citations
13.
Pinkston, P, et al.. (1995). Quantitative Culture of HIV-1 From Bronchoalveolar Lavage Cells. American Journal of Respiratory and Critical Care Medicine. 152(1). 254–259. 7 indexed citations
14.
Ortonne, J P, et al.. (1978). [Vitiligo and cutaneous epitheliomas].. PubMed. 105(12). 1063–4. 7 indexed citations
15.
Pelletier, Nadège, A Claudy, & J Thivolet. (1978). Evaluation de facteurs pronostiques du mélanome malin par la méthode actuarielle. Dermatology. 157(4). 210–220. 2 indexed citations
16.
Claudy, A, et al.. (1975). [Value of thymodependant rosette tests in the surveillance of malignant melanoma. Preliminary study apropos of 25 cases].. PubMed. 102(1). 69–70. 1 indexed citations
17.
Claudy, A, et al.. (1975). Prognostic correlations in malignant melanoma. European Journal of Cancer (1965). 11(11). 821–827. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026